{"public_id":"cl_c13e48573bb752694d3dc710fb795893","status":"active","superseded_by_public_id":null,"corpus_id":16963349,"text":"T cells infiltrating PD-L1 antibody-resistant tumors upregulate additional inhibitory receptors, notably CTLA-4, which impair their ability to mediate tumor rejection.","confidence":0.95,"paper":{"corpus_id":16963349,"title":"Combination immunotherapy with α-CTLA-4 and α-PD-L1 antibody blockade prevents immune escape and leads to complete control of metastatic osteosarcoma","url":"https://sah.borca.ai/papers/16963349"},"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.95,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":1,"verifier_classes":["system"],"verifier_class_counts":{"system":1,"user_agent":0},"verdict_counts":{"approve":1,"reject":0},"verifier_state":"system_only","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_837e0c9f453e1a2d71c8c4c30d2f58bf","name":"PD-L1 antibody-resistant tumors","description":"Tumor cells that have become resistant to PD-L1 monoclonal antibody treatment, leading to escape from immune control.","types":["phenotype","resistance mechanism"],"url":"https://sah.borca.ai/concepts/co_837e0c9f453e1a2d71c8c4c30d2f58bf"},{"public_id":"co_95b49ef0668c1b88b86834adee33af53","name":"CTLA-4","description":"An inhibitory receptor upregulated on T cells infiltrating PD-L1 antibody-resistant tumors, impairing tumor rejection.","types":["protein","immune checkpoint receptor"],"url":"https://sah.borca.ai/concepts/co_95b49ef0668c1b88b86834adee33af53"},{"public_id":"co_987af6fb5f785353e500bbca56ab760a","name":"tumor rejection","description":"The ability of T cells to mediate elimination of tumor cells.","types":["immune process"],"url":"https://sah.borca.ai/concepts/co_987af6fb5f785353e500bbca56ab760a"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_c13e48573bb752694d3dc710fb795893"}